[1]
|
Basso, C., Corrado, D., Marcus, F.I. and Nava, A. (2009) Arrhythmogenic Right Ventricular Cardiomyopathy. Lancet, 373, 1289-1300. https://doi.org/10.1016/S0140-6736(09)60256-7
|
[2]
|
Liang, J., Goodsell, K., Grogan, M. and Ackerman, M.J. (2014) LMNA-Mediated _ARVC_ and Charcot-Marie Tooth Type 2B1: A Patient-Discovered Unifying Diagnosis. 35th Annual Heart Rhythm 2014, San Francisco, 4 September 2014, 868-871.
|
[3]
|
Chen, X., Chen, L., Chen, Z., Chen, X. and Song, J. (2017) Remodelling of Myocardial Intercalated Disc Protein Connexin 43 Causes Increased Susceptibility To malignant Arrhythmias in ARVC/D Patients. Forensic Science International, 275, 14-22. https://doi.org/10.1016/j.forsciint.2017.02.020
|
[4]
|
Saffitz, J.E. (2009) Arrhythmogenic Cardiomyopathy and Abnormalities of Cell-to-Cell Coupling. Heart Rhythm, 6, S62-S65. https://doi.org/10.1016/j.hrthm.2009.03.003
|
[5]
|
Dalal, D., Jain, R., Tandri, H., Dong, J., Eid, S.M., Prakasa, K., et al. (2007) Long-Term Efficacy of Catheter Ablation of Ventricular Tachycardiain Patients with Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Journal of the American College of Cardiology, 50, 432-440. https://doi.org/10.1016/j.jacc.2007.03.049
|
[6]
|
房清丽, 李自青, 闫玉清, 高晔, 邢雁霞, 张年萍, 等. 致心律失常性右室心肌病研究进展[J]. 山西大同大学学报: 自然科学版, 2019, 35(5): 44-48.
|
[7]
|
Corrado, D., van Tintelen, P.J., McKenna, W.J., Hauer, R.N.W., Anastastakis, A., Asimaki, A., et al. (2020) Arrhythmogenic Right Ventricular Cardiomyopathy: Evaluation of the Current Diagnostic Criteria and Differential Diagnosis. European Heart Journal, 41, 1414-1429.
|
[8]
|
Romero, J., Mejia-Lopez, E., Manrique, C. and Lucariello, R. (2013) Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC/D): A Systematic Literature Review. Clinical Medicine Insights: Cardiology, 7, 97-114.
https://doi.org/10.4137%2FCMC.S10940
|
[9]
|
Delmar, M. (2016) ARVC/D and the Dyad: A Long Distance Relationship? Heart Rhythm, 13, 742.
https://doi.org/10.1016/j.hrthm.2015.11.036
|
[10]
|
Neto, J.E., Tonet, J., Frank, R. and Fontaine, G. (2019) Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D)—What We Have Learned after 40 Years of the Diagnosis of This Clinical Entity. Arquivos Brasileiros de Cardiologia, 112, 91-103. https://doi.org/10.5935/abc.20180266
|
[11]
|
Wang, Y., Li, C., Shi, L., Chen, X., Cui, C., Huang, J., et al. (2020) Integrin β1D Deficiency-Mediated RyR2 Dysfunction Contributes to Catecholamine-Sensitive Ventricular Tachycardia in ARVC. Circulation, 141, 1477-1493.
https://doi.org/10.1161/CIRCULATIONAHA.119.043504
|
[12]
|
梁士楚, 王翠, 常龄予, 张士涵, 赵韧, 沈兵. 基于GEO数据库芯片的致心律失常性右室心肌病关键基因筛选与生物信息学分析[J]. 临床心血管病杂志, 2020, 36(6): 516-522.
|
[13]
|
Marcus, F., Edson, S. and Towbin, J.A. (2013) Genetics of Arrhythmogenic Right Ventricular Cardiomyopathy: A Practical Guide for Physicians. Journal of the American College of Cardiology, 61, 1945-1948.
https://doi.org/10.1016/j.jacc.2013.01.073
|
[14]
|
Marcus, F.I., McKenna, W.J., Sherrill, D., Basso, C., Bauce, B., Bluemke, D.A., et al. (2010) Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria. Circulation, 121, 1533-1541. https://doi.org/10.1161/CIRCULATIONAHA.108.840827
|
[15]
|
Wang, W., James, C.A. and Calkins, H. (2018) Diagnostic and Therapeutic Strategies for Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patient. EP Europace, 21, 9-21.
https://doi.org/10.1093/europace/euy063
|
[16]
|
Pinamonti, B., Brun, F., Mestroni, L. and Sinagra, G. (2014) Arrhythmogenic Right Ventricular Cardiomyopathy: From Genetics to Diagnostic and Therapeutic Challenges. World Journal of Cardiology, 6, 1234-1244.
https://doi.org/10.4330/wjc.v6.i12.1234
|
[17]
|
Femia, G., Sy, R.W. and Puranik, R. (2017) Systematic Review: Impact of the New Task Force Criteria in the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy. International Journal of Cardiology, 241, 311-317.
https://doi.org/10.1016/j.ijcard.2017.03.069
|
[18]
|
Li, K.H.C., Bazoukis, G., Liu, T., Li, G., Wu, W.K.K., Wong, S.H., et al. (2018) Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D) in Clinical Practice. Journal of Arrhythmia, 34, 11-22.
https://doi.org/10.1002/joa3.12021
|
[19]
|
Peters, S. (2015) Prognostic Value of Epsilon Waves in Lead a VR in Arrhythmogenic Cardiomyopathy. International Journal of Cardiology, 191, 77-78. https://doi.org/10.1016/j.ijcard.2015.04.261
|
[20]
|
Protonotarios, A., Anastasakis, A., Tsatsopoulou, A., Antoniades, L., Prappa, E., Syrris, P., et al. (2015) Clinical Significance of Epsilon Waves in Arrhythmogenic Cardiomyopathy. Journal of Cardiovascular Electrophysiology, 26, 1204-1210. https://doi.org/10.1111/jce.12755
|
[21]
|
Wang, J., Yang, B., Chen, H., Ju, W., Chen, K., Zhang, F., et al. (2010) Epsilon Waves Detected by Various Electrocardiographic Recording Methods in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy. Texas Heart Institute Journal, 37, 405-411.
|
[22]
|
杨丹丹. 广义Epsilon波(178) [J]. 临床心电学杂志, 2019(3): 235.
|
[23]
|
Li, G.L., Saguner, A.M., Akdis, D. and Fontaine, G.H. (2018) Value of a Novel 16-Lead High-Definition ECG Machine to Detect Conduction Abnormalities in Structural Heart Disease. Pacing and Clinical Electrophysiology, 41, 643-655. https://doi.org/10.1111/pace.13338
|
[24]
|
焦琳, 黄新锐, 吴双, 范倩, 赵芳. 致心律失常型右室心肌病合并左室受累1例报告[J]. 中国循证心血管医学杂志 2020, 12(12): 1530-1531, 1537.
|
[25]
|
孔令秋, 康彧, 唐红, 付华, 杨庆, 姜建. 超声诊断致心律失常性右心室心肌病的临床价值再评价[J]. 中华超声影像学杂志, 2013, 22(9): 737-740.
|
[26]
|
周敏, 雍永宏, 姬后亮, 刘剑秋, 高翔, 舒开凤. 超声心动图联合心电图对致心律失常性右室心肌病的诊断价值[J]. 2018, 39(9): 56-59.
|
[27]
|
Haugaa, K.H., Basso, C., Badano, L.P., Bucciarelli-Ducci, C., Cardim, N., Gaemperli, O., Galderisi, M., Habib, G., et al. (2017) Comprehensive Multi-Modality Imaging Approach in Arrhythmogenic Cardiomyopathy—An Expert Consensus Document of the European Association of Cardiovascular Imaging. European Heart Journal-Cardiovascular Imaging, 18, 237-253. https://doi.org/10.1093/ehjci/jew229
|
[28]
|
沈梦婷, 杨志刚, 叶璐, 刁凯悦, 蒋丽, 张怡. 致心律失常性右室心肌病的磁共振诊断价值及研究进展[J]. 磁共振成像, 2019, 10(6): 469-473.
|
[29]
|
Aquaro, G.D., Barison, A., Todiere, G., Grigoratos, C., Ait Ali, L., Di Bella, G., et al. (2016) Usefulness of Combined Functional Assessment by Cardiac Magnetic Resonance and Tissue Characterization versus Task Force Criteria for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy. American Journal of Cardiology, 118, 1730-1736.
https://doi.org/10.1016/j.amjcard.2016.08.056
|
[30]
|
Philips, B. and Cheng, A. (2016) 2015 Update on the Diagnosis and Management of Arrhythmogenic Right Ventricular Cardiomyopathy. Current Opinion in Cardiology, 31, 46-56. https://doi.org/10.1097/HCO.0000000000000240
|
[31]
|
Corrado, D., Link, M.S. and Calkins, H. (2017) Arrhythmogenic Right Ventricular Cardiomyopathy. New England Journal of Medicine, 376, 61-72. https://doi.org/10.1056/NEJMra1509267
|
[32]
|
Corrado, D., Basso, C. and Judge, D.P. (2017) Arrhythmogenic Cardiomyopathy. Circulation Research, 121, 784-802.
https://doi.org/10.1161/CIRCRESAHA.117.309345
|
[33]
|
杨丰菁, 刘文玲. 致心律失常性右室心肌病新观点[J]. 实用心电学杂志, 2021, 30(1): 59-63.
|
[34]
|
Asimaki, A., Kleber, A.G. and Saffitz, J.E. (2015) Pathogenesis of Arrhythmogenic Cardiomyopathy. Canadian Journal of Cardiology, 31, 1313-1324. https://doi.org/10.1016/j.cjca.2015.04.012
|
[35]
|
Corrado, D., Wichter, T., Link, M.S., Hauer, R., Marchlinski, F., Anastasakis, A., et al. (2015) Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement. European Heart Journal, 36, 3227-3237. https://doi.org/10.1093/eurheartj/ehv162
|
[36]
|
Ermakov, S., Gerstenfeld, E.P., Svetlichnaya, Y. and Scheinman, M.M. (2017) Use of Flecainide in Combination Antiarrhythmic Therapy in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy. Heart Rhythm, 14, 564-569.
https://doi.org/10.1016/j.hrthm.2016.12.010
|
[37]
|
Towbin, J.A., McKenna, W.J., Abrams, D.J., Ackerman, M.J., Calkins, H., Darrieux, F.C.C., et al. (2019) 2019 HRS Expert Consensus Statement on Evaluation, Risk Stratification, and Management of Arrhythmogenic Cardiomyopathy: Executive Summary. Heart Rhythm, 16, e373-e407. https://doi.org/10.1016/j.hrthm.2019.09.019
|
[38]
|
Silvano, M., Corrado, D., Kobe, J., Mönnig, G., Basso, C., Thiene, G., et al. (2013) Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy. Herzschrittmacherther + Elektrophysiol, 24, 202-208.
https://doi.org/10.1007/s00399-013-0291-5
|
[39]
|
Bai, R., Di Biase, L., Shivkumar, K., Mohanty, P., Tung, R., Santangeli, P., et al. (2011) Ablation of Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Arrhythmia-Free Survival after endo-Epicardial substrate based mapping and ablation. Circulation: Arrhythmia and Electrophysiology, 4, 478-485.
https://doi.org/10.1161/CIRCEP.111.963066
|
[40]
|
Romero, J., Grushko, M., Briceno, D.F., Natale, A. and Di Biase, L. (2017) Radiofrequency Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC). Current Cardiology Reports, 19, Article No. 82.
https://doi.org/10.1007/s11886-017-0893-3
|
[41]
|
Mussigbrodt, A., Efimova, E., Knopp, H., Bertagnolli, L., Dagres, N., Richter, S., et al. (2017) Epicardial Ablation May Not Be Necessary in All Patients with Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and Frequent Ventricular Tachycardia. EP Europace, 19, 2047. https://doi.org/10.1093/europace/eux004
|
[42]
|
Liao, Y.C., Chung, F.P., Lin, Y.J., Chang, S.L., Lo, L.W., Hu, Y.F., et al. (2017) The Application of Signal Average ECG in the Prediction of Recurrences after Catheter Ablation of Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. International Journal of Cardiology, 236, 168-173.
https://doi.org/10.1016/j.ijcard.2017.01.087
|